BL
Bleichroeder LP’s Cue Biopharma CUE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.65M | Buy |
6,819,164
+1,821,924
| +36% | +$1.24M | 1.14% | 14 |
|
2025
Q1 | $4.55M | Hold |
4,997,240
| – | – | 1.21% | 14 |
|
2024
Q4 | $5.45M | Hold |
4,997,240
| – | – | 1.37% | 14 |
|
2024
Q3 | $3.78M | Buy |
4,997,240
+2,135,634
| +75% | +$1.62M | 1.02% | 13 |
|
2024
Q2 | $3.55M | Buy |
2,861,606
+106,578
| +4% | +$132K | 1.06% | 17 |
|
2024
Q1 | $5.21M | Buy |
2,755,028
+1,000,000
| +57% | +$1.89M | 1.3% | 18 |
|
2023
Q4 | $4.63M | Buy |
1,755,028
+1,000,000
| +132% | +$2.64M | 1.03% | 16 |
|
2023
Q3 | $1.74M | Hold |
755,028
| – | – | 0.43% | 24 |
|
2023
Q2 | $2.76M | Hold |
755,028
| – | – | 0.56% | 25 |
|
2023
Q1 | $2.7M | Sell |
755,028
-106,250
| -12% | -$379K | 0.58% | 23 |
|
2022
Q4 | $2.45M | Buy |
861,278
+306,278
| +55% | +$873K | 0.53% | 27 |
|
2022
Q3 | $1.24M | Hold |
555,000
| – | – | 0.26% | 36 |
|
2022
Q2 | $1.38M | Buy |
555,000
+3,000
| +0.5% | +$7.47K | 0.29% | 36 |
|
2022
Q1 | $2.69M | Buy |
552,000
+352,000
| +176% | +$1.72M | 0.48% | 34 |
|
2021
Q4 | $2.26M | Buy |
200,000
+25,000
| +14% | +$283K | 0.35% | 42 |
|
2021
Q3 | $2.55M | Hold |
175,000
| – | – | 0.41% | 41 |
|
2021
Q2 | $2.04M | Buy |
175,000
+100,000
| +133% | +$1.17M | 0.31% | 44 |
|
2021
Q1 | $915K | Hold |
75,000
| – | – | 0.15% | 47 |
|
2020
Q4 | $938K | Sell |
75,000
-75,000
| -50% | -$938K | 0.18% | 42 |
|
2020
Q3 | $2.26M | Sell |
150,000
-15,000
| -9% | -$226K | 0.4% | 35 |
|
2020
Q2 | $4.04M | Hold |
165,000
| – | – | 0.72% | 27 |
|
2020
Q1 | $2.34M | Hold |
165,000
| – | – | 0.61% | 29 |
|
2019
Q4 | $2.62M | Buy |
+165,000
| New | +$2.62M | 0.41% | 27 |
|